Therapy of lupus nephritis: lessons learned from clinical research and daily care of patients
Open Access
- 1 January 2012
- journal article
- review article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 14 (1) , 202
Abstract
Despite numerous randomized clinical trials over the last three decades for identifying the optimal treatment option for lupus nephritis, renal involvement still significantly impacts the survival and quality of life of patients with lupus and the search for the ideal immunosuppressive regimen is far from complete. The purpose of this review is to summarize the major recent achievements in the field. More specifically, the following topics will be discussed: intravenous cyclophosphamide versus mycophenolate mofetil (MMF) for induction; azathioprine versus MMF for maintenance; targeted therapies. The review will address clues for optimal global care, such as the need for complete initial evaluation, the importance of patient education, the unmasking of non-compliance to therapy, the reason for an early treatment switch in non-responding patients, the need for prolonged immunosuppression, optimal renal protection, and prevention of cardiovascular disease and other comorbidities.Keywords
This publication has 34 references indexed in Scilit:
- Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis TrialNephrology Dialysis Transplantation, 2011
- Sequential Therapies for Proliferative Lupus NephritisNew England Journal of Medicine, 2004
- Premature Coronary-Artery Atherosclerosis in Systemic Lupus ErythematosusNew England Journal of Medicine, 2003
- Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus ErythematosusNew England Journal of Medicine, 2003
- Immunosuppressive therapy in lupus nephritis: The Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamideArthritis & Rheumatism, 2002
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995
- Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritisThe Lancet, 1992
- Short Course of Weekly Low-Dose Intravenous Pulse Cyclophosphamide in the Treatment of Lupus Nephritis: A Preliminary StudyLupus, 1991
- Therapy of Lupus NephritisNew England Journal of Medicine, 1986
- The bimodal mortality pattern of systemic lupus erythematosusThe American Journal of Medicine, 1976